A family based study of catechol‐O‐methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD)
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Neurobiological studies have suggested that altered dopaminergic function may contribute to the etiology of attention deficit hyperactivity disorder (ADHD). The gene encoding catechol‐O‐methyltransferase (COMT) is an attractive candidate for ADHD susceptibility as it plays a major role in the degradation of dopamine. Moreover, a functional Val158Met polymorphism in COMT that alters the activity of the encoded protein has been strongly implicated in frontal lobe function, with the high activity Valine allele being associated with poorer performance, and ADHD is thought to involve fronto‐striatal pathways. We have examined this functional variant for association with ADHD in a family based association sample comprising 279 probands and their parents. We have also examined two other markers in the COMT gene (rs737865, rs165599) which, together with the Val/Met variant, have recently been shown to be associated with altered COMT expression rather than enzyme activity. No evidence for association was observed with any single marker or haplotype in a sample of 279 affected children and their parents. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C. R., Simmons, A., & Bullmore, E. T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.891 · Cited by 1,010
The Child and Adolescent Psychiatric Assessment (CAPA)
Angold, A., Prendergast, M., Cox, A., Harrington, R., Simonoff, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s003329170003498x · Cited by 968 · cited 1×
“Mothers were interviewed about their children, using the Child and Adolescent Psychiatric Assessment (CAPA) [Angold et al., 1995], a research diagnostic interview.”
MethodNeurobiology of attention-deficit hyperactivity disorder
Faraone, S. V., & Biederman, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00240-6 · Cited by 811
CASEY, B. J., CASTELLANOS, F. X., GIEDD, J. N., MARSH, W. L., HAMBURGER, S. D., SCHUBERT, A. B., VAUSS, Y. C., VAITUZIS, A. C., DICKSTEIN, D. P., SARFATTI, S. E., et al. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199703000-00016 · Cited by 800 · cited 2×
“Neuropsychological [Rubia et al., 2001] and functional brain imaging studies [Casey et al., 1997; Rubia et al., 1999] have suggested that fronto-striatal areas in the brain rich in dopaminergic innervation may be affected.”
BackgroundGenetic and neurochemical modulation of prefrontal cognitive functions in children
Diamond, A., Briand, L., Fossella, J., & Gehlbach, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.125 · Cited by 381 · cited 2×
“, 1996], and has been convincingly implicated in poorer frontal lobe function across a number of cognitive tasks [Egan et al., 2001; Bilder et al., 2002; Malhotra et al., 2002; Goldberg et al., 2003; Diamond et al., 2004].”
BackgroundKarayiorgou, M., Altemus, M., Galke, B. L., Goldman, D., Murphy, D. L., Ott, J., & Gogos, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4572 · Cited by 304
Arnold, L. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210113015 · Cited by 240 · cited 1×
“Pharmacological studies have shown that stimulant medication, such asmethylphenidate, helps to alleviate symptoms in 70%– 90% of treated children [Taylor, 1994; Arnold et al., 1997].”
BackgroundQian, Q., Wang, Y., Zhou, R., Li, J., Wang, B., Glatt, S., & Faraone, S. V. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10064 · Cited by 113 · cited 2×
“In the light of reports of gender-based differences in association to psychiatric diseases, and also in allele and genotype frequencies at the COMT locus [Karayiorgou et al., 1997; Shifman et al., 2002; Qian et al., 2003] we calculated gender specific allele frequencies.”
Background
Cited by
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Attention-deficit-hyperactivity disorder and reward deficiency syndrome
Oscar Berman, M., Blum, K., Chen, T. J., Braverman, E., Waite, R., Downs, W., Arcuri, V., Notaro, A., Palomo, T., & Comings (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2627 · Cited by 248
“Other genes that have been associated with ADHD susceptibility include the calcyon gene (DRD11p) (Laurin et al 2005); beta hydroxylase gene (Inkster et al 2004) NR4A2 gene (Smith et al 2005) and the COMT gene (Turic et al 2005b).”
BackgroundCaspi, A., Langley, K., Milne, B., Moffitt, T. E., O’Donovan, M., Owen, M. J., Polo Tomas, M., Poulton, R., Rutter, M., Taylor, A., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.24 · Cited by 221
Self-citationCraddock, N., Owen, M. J., & O'Donovan, M. C. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001808 · Cited by 216
Self-citationCatechol‐O‐methyltransferase and Its Inhibitors in Parkinson's Disease
Bonifácio, M. J., Palma, P. N., Almeida, L., & Soares‐da‐Silva, P. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00020.x · Cited by 199
“1997, 2001), attention deficit hyperactivity disorder (Mills et al. 2004; Taerk et al. 2004; Turic et al. 2005), schizophrenia (Egan et al.”
Background
Metadata
- Authors
- Turic, D., Williams, H., Langley, K., Owen, M., Thapar, A., & O'Donovan, M. C.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2005-01-05
- Volume
- 133B
- Issue
- 1
- Pages
- 64-67
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2033175857
- Cited by
- 30
- References
- 9
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.